Thermo Fisher Scientific Inc. (TMO) Stake Lowered by Daiwa Securities Group Inc.

Daiwa Securities Group Inc. lowered its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) by 13.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 43,094 shares of the medical research company’s stock after selling 6,539 shares during the quarter. Daiwa Securities Group Inc.’s holdings in Thermo Fisher Scientific were worth $8,183,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Covington Capital Management grew its position in Thermo Fisher Scientific by 0.9% in the 2nd quarter. Covington Capital Management now owns 2,144 shares of the medical research company’s stock valued at $374,000 after purchasing an additional 20 shares during the period. Investment Centers of America Inc. grew its position in Thermo Fisher Scientific by 1.6% in the 2nd quarter. Investment Centers of America Inc. now owns 1,317 shares of the medical research company’s stock valued at $230,000 after purchasing an additional 21 shares during the period. Fort Washington Investment Advisors Inc. OH grew its position in Thermo Fisher Scientific by 0.4% in the 2nd quarter. Fort Washington Investment Advisors Inc. OH now owns 6,250 shares of the medical research company’s stock valued at $1,090,000 after purchasing an additional 23 shares during the period. Bienville Capital Management LLC grew its position in Thermo Fisher Scientific by 1.6% in the 2nd quarter. Bienville Capital Management LLC now owns 1,687 shares of the medical research company’s stock valued at $295,000 after purchasing an additional 27 shares during the period. Finally, Monetary Management Group Inc. grew its position in Thermo Fisher Scientific by 0.6% in the 2nd quarter. Monetary Management Group Inc. now owns 12,150 shares of the medical research company’s stock valued at $2,120,000 after purchasing an additional 75 shares during the period. 86.31% of the stock is owned by institutional investors and hedge funds.

Several analysts recently issued reports on the stock. Morgan Stanley lifted their price target on shares of Thermo Fisher Scientific from $223.00 to $227.00 and gave the company an “overweight” rating in a research report on Thursday, February 1st. Barclays lifted their price target on shares of Thermo Fisher Scientific from $225.00 to $245.00 and gave the company an “overweight” rating in a research report on Thursday, February 1st. Leerink Swann reissued an “outperform” rating and issued a $239.00 price target (up previously from $200.00) on shares of Thermo Fisher Scientific in a research report on Thursday, February 1st. They noted that the move was a valuation call. ValuEngine raised shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating in a research report on Friday, February 2nd. Finally, Bank of America lifted their price target on shares of Thermo Fisher Scientific from $235.00 to $250.00 and gave the company a “buy” rating in a research report on Thursday, February 1st. Two research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $220.50.

In other news, insider Patrick M. Durbin sold 6,000 shares of Thermo Fisher Scientific stock in a transaction on Monday, February 5th. The stock was sold at an average price of $217.55, for a total transaction of $1,305,300.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CFO Stephen Williamson sold 5,000 shares of Thermo Fisher Scientific stock in a transaction on Wednesday, February 7th. The stock was sold at an average price of $209.26, for a total value of $1,046,300.00. Following the sale, the chief financial officer now owns 30,741 shares in the company, valued at $6,432,861.66. The disclosure for this sale can be found here. Insiders have sold a total of 144,327 shares of company stock worth $28,680,042 over the last quarter. Company insiders own 0.49% of the company’s stock.

Thermo Fisher Scientific Inc. (NYSE TMO) opened at $200.18 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.92 and a current ratio of 1.35. Thermo Fisher Scientific Inc. has a 52 week low of $151.74 and a 52 week high of $226.44. The firm has a market capitalization of $80,430.00, a price-to-earnings ratio of 35.75, a price-to-earnings-growth ratio of 1.46 and a beta of 1.11.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings data on Wednesday, January 31st. The medical research company reported $2.79 earnings per share for the quarter, beating the consensus estimate of $2.66 by $0.13. Thermo Fisher Scientific had a return on equity of 16.01% and a net margin of 10.64%. The business had revenue of $6.05 billion for the quarter, compared to analysts’ expectations of $5.72 billion. During the same period last year, the business earned $2.41 EPS. The business’s revenue was up 22.1% on a year-over-year basis. equities research analysts anticipate that Thermo Fisher Scientific Inc. will post 10.81 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, April 16th. Stockholders of record on Thursday, March 15th will be paid a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.34%. This is a boost from Thermo Fisher Scientific’s previous quarterly dividend of $0.15. The ex-dividend date of this dividend is Wednesday, March 14th. Thermo Fisher Scientific’s payout ratio is presently 10.71%.

COPYRIGHT VIOLATION WARNING: “Thermo Fisher Scientific Inc. (TMO) Stake Lowered by Daiwa Securities Group Inc.” was originally reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this piece on another website, it was stolen and republished in violation of US & international trademark & copyright laws. The correct version of this piece can be accessed at https://sportsperspectives.com/2018/02/11/thermo-fisher-scientific-inc-tmo-stake-lowered-by-daiwa-securities-group-inc.html.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply